Home › NDC Lookup › Ingredients › Petrolatum, Cod Liver Oil › 79974-0202-01
CUREFINI Petrolatum, Cod Liver Oil 300 mg/mL; 100 mg/mL Ointment, 30 mL — NDC 79974-0202-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

CUREFINI Petrolatum, Cod Liver Oil 300 mg/mL; 100 mg/mL Ointment, 30 mL — NDC 79974-202-01 (Billing 79974-0202-01)

by Miramar Cosmetics, Inc DBA Miramar Lab · 30 mL in 1 JAR

This is a package of 30 mL of CUREFINI Petrolatum, Cod Liver Oil 300 mg/mL; 100 mg/mL Ointment from Miramar Cosmetics, Inc DBA Miramar Lab, marketed since Jun 2022 and currently FDA-listed. It is the main listing for this product, which comes in 4 package sizes.

NDC 79974-0202-01
🏷️ FDA NDC (as labeled) 79974-202-01 billing pads the product segment with a zero
This package
Contains30 mL Pack sizes4 compare ↓
Main listing for product 79974-202 · Also comes in: 60 ml 79974-202-02 120 ml 79974-202-04 240 ml 79974-202-08
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 79974-202-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
79974 labeler · 202 product · 01 package
Package marketed since
Jun 1, 2022
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 7997420201 8
FDA record last changed
Aug 27, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 79974-202-01
Product NDC 79974-202
11-digit billing NDC 79974020201
RxCUI 1440007
UNII 4T6H12BN9U, BBL281NWFG
Application # M016
SPL Set ID fc9211db-71aa-44d8-a00b-65f1482d3981
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2022-06-01
Route TOPICAL
Dosage form OINTMENT
Substance PETROLATUM; COD LIVER OIL
Quick answers
  • RxCUI (RxNorm): 1440007
Why two NDCs? The FDA registers this code as 79974-202-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 79974-0202-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

Curefini is a topical ointment containing petrolatum and cod liver oil, marketed as an over-the-counter monograph product. Petrolatum functions as an occlusive moisturizer and skin protectant, commonly used to soften and protect dry or irritated skin. Cod liver oil is typically included in such products for its fatty acid content, which is believed to support skin conditioning. This ointment is applied directly to the skin surface.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 60 ml 120 ml 240 ml
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
79974-0202-01 You're viewing this Main listing 30 mL in 1 JAR 2022-06-01 — Active
79974-0202-02 79974-202-02 60 mL in 1 JAR 2022-06-01 — Active
79974-0202-04 79974-202-04 120 mL in 1 JAR 2022-06-01 — Active
79974-0202-08 79974-202-08 240 mL in 1 JAR 2022-06-01 — Active

You're viewing the smallest of 4 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This package contains 30 mL — 30 ml in 1 jar.
How does this package differ from NDC 79974-0202-02?
Both are CUREFINI Petrolatum, Cod Liver Oil 300 mg/mL; 100 mg/mL Ointment — the drug itself is identical. This page's package is the 30 mL one, while NDC 79974-0202-02 is the 60 ml package.
What NDC number is used to bill for this package of CUREFINI Petrolatum, Cod Liver Oil 300 mg/mL; 100 mg/mL Ointment?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Curefini 100 mg/mL; 300 mg/mL 65121-0712-64 Pure 120 ml — — Discontinued —
CUREFINI Dermal 300 mg/mL; 100 mg/mL 69981-0704-01 Rev 30 ml — — Discontinued —
CURACID Dermal for cuts and burns 300 mg/mL; 100 mg/mL 69981-0710-04 Rev 120 ml — — Discontinued —
Curefini 300 mg/mL; 100 mg/mL 69981-0712-64 Rev 120 ml — — Discontinued —
Curefini Dermal 300 mg/mL; 100 mg/mL 69981-0754-01 Rev 120 ml — — Discontinued —
Curefini 300 mg/mL; 100 mg/mLthis 79974-0202-01 Miramar 30 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2022
On the market since
Jun 2022
📍
2026
Currently FDA-listed
4 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 66YXD4DKO9
    A natural oil extracted from almond kernels. It's used in medicines as an emollient and solvent to help dissolve or suspend active ingredients and improve texture in topical and oral formulations.
  • UNII 1P9D0Z171K
    BHT is a synthetic antioxidant that prevents fats and oils in medicines from breaking down and becoming rancid. It helps keep the product stable and effective during storage.
  • UNII FGL3685T2X
    Chamomile is a plant extract used in medications as a flavoring agent and for its mild soothing properties in formulations. It helps improve taste and aroma of the medicine.
  • UNII BKJ0J3D1BP
    A plant-derived ingredient from sunflower flowers, used as a natural colorant and flavoring agent in medicines. It may help provide color or mild taste to the product.
  • UNII 2ZA36H0S2V
    Beeswax is a natural wax produced by honeybees. In medicines, it works as a coating agent and thickener to control how fast the drug dissolves and improve the product's texture and appearance.

5 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesBeeswax, BHT, Chamomilla Recutita (Chamomile) Oil, Helianthus Annuus (Sunflower) Oil, Prunus Amygdalus Dulcis (Sweet Almond) Oil.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerMiramar Cosmetics, Inc DBA Miramar Lab
FDA applicationM016 (OTC MONOGRAPH DRUG)
Labeler code79974
First marketedJun 2022
Product typeHuman Otc Drug
Portfolio7 products on file

More NDCs from Miramar Cosmetics, Inc DBA Miramar Lab labeler code 79974

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 27 words ▾

Uses: • Temporarily protects minor cuts, scrapes and burns. • Temporarily protects chapped or cracked skin. • Helps protect from drying effects of wind and cold weather.

⏱️ Dosage and Administration 49 words ▾

Directions: Apply as needed. Prepare a gauze bandage to apply. Dressing should be placed on a clean and flat surface. Apply ointment with a spatula, covering the entire surface with a thin layer. Place bandage directly on top of affected area. Make sure affected area remains covered by ointment.

⚠️ Warnings 64 words ▾

Warnings: • For external use only. • When using this product, do not get into eyes. • If condition worsens or does not improve for seven days, discontinue use and consult a physician. • DO NOT USE IF TAMPER EVIDENT SEAL IS BROKEN. Keep out of reach of children. If swallowed, contact physician or poison control center immediately. Other Information: Store at room temperature.

📦 Storage and Handling 6 words ▾

Other Information: Store at room temperature.

🧪 Active Ingredient 8 words ▾

Active Ingredients: Petrolatum 30.00% Cod Liver Oil 10.00%

🧪 Inactive Ingredients 18 words ▾

Inactive Ingredients: Beeswax, BHT, Chamomilla Recutita (Chamomile) Oil, Helianthus Annuus (Sunflower) Oil, Prunus Amygdalus Dulcis (Sweet Almond) Oil.

🎯 Purpose 3 words ▾

Purpose: Skin Protectant

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. If swallowed, contact physician or poison control center immediately. Other Information: Store at room temperature.

📄 Package Label / Principal Display Panel 2 words ▾

Packaging curefiniointment

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for CUREFINI (this brand).

Top reported reactions

Rash45
Pneumonia31
Pruritus31
Cellulitis29
Dyspnoea24
Urinary Tract Infection24
Dizziness23

Age at onset

Neonate5
Infant3
Child9
Adolescent3
Adult57
Elderly59

Reporter sex

435 reports
Male · 55%
Female · 45%

Serious outcomes

Hospitalization260
Death72
Life-threatening49
Disabling8
Reports over time (by year) — tap or hover for the count & year
2021 2022 2024 2026 61 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Miramar Cosmetics, Inc DBA Miramar Lab. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 60 ml (79974-0202-02), 120 ml (79974-0202-04), 240 ml (79974-0202-08). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Miramar Cosmetics, Inc DBA Miramar Lab is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 79959-0011-01 · APR 79974-0203-02 · Miramar →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.